Latest Interviews
Showing 1231–1245 of 1,990 transcripts.
Clear all filters- Milken Institute56 min
Health-care Disruptors: New Models Changing the Landscape
Casey Ross, Ray Dorsey, Joel Dudley, Andrea Feinberg, Dan Liljenquist
A multidisciplinary panel led by Dr. Ray Dorsey, Dan Liljenquist, Dr. Andrea Feinberg, and Dr. Joel Dudley addressed critical healthcare failures, highlighting how telemedicine, generic drug shortages, nutritional interventions, and data fragmentation impact patient outcomes and system efficiency. The speakers detailed successful pilot programs, including University of Rochester's home-based Parkinson's care, CivicaRx's nonprofit generic manufacturing model, Geisinger's Fresh Food Pharmacy, and Mount Sinai's data-driven precision health initiatives, all of which demonstrated significant reductions in costs and mortality. Despite these proven efficacy metrics, the discussion underscored that widespread scalability remains constrained by rigid Medicare reimbursement policies, regulatory limits on social determinants of care, and fragmented data infrastructure that prevents algorithmic integration.
- Y Combinator55 min
After PMF: People, Customers, Sales by Mathilde Collin
Mathilde Cullen co-founded Front with Laurent Dufaux in Y Combinator's Summer 2014 batch to build an email collaboration platform that achieved zero voluntary attrition through a culture of radical transparency and a rigorous "10x hire" recruitment strategy. The company secured early product-market fit by prioritizing direct customer feedback, which led to a strategic pivot adding SMS integration and a pricing evolution from a freemium model to higher-tier subscriptions. By adhering to disciplined weekly metrics, maintaining a bottom-up sales motion, and fostering deep co-founder alignment, Front successfully scaled while navigating leadership challenges including the CTO's cancer diagnosis.
- Y Combinator55 min
The Path to $100B by Paul Buchheit
Google co-founder Paul Buchheit outlines the critical success factors for building billion-dollar companies, emphasizing the necessity of focusing on an exponential market shift and achieving deep product-market fit with a small, obsessive user base before scaling. Drawing from his experiences launching Gmail and selling FriendFeed to Facebook, Buchheit argues that startups must prioritize frugality, customer obsession, and the ability to handle network effects rather than chasing broad appeal or reacting to competitors. His framework stresses that true growth emerges from solving urgent customer problems with irrational conviction, a discipline he believes is often lost in large organizations that lack the cultural DNA for product-led innovation.
- Jane Street1h 7m
Marius Eriksen: Distributed, Incremental Dataflow Processing in the Cloud with Reflow
The Braille bioinformatics team has developed Reflow, an open-source workflow engine designed to treat biological data pipelines as functional programs rather than static dependency graphs. By enforcing a strict data model and dynamic cloud resource provisioning, the system automatically parallelizes tasks, caches results through referential transparency, and ensures reproducible computations via versioned "data spaces." Currently adopted by Grail, the Chan Zuckerberg Institute, and several biotech startups, Reflow reduces infrastructure complexity while enabling efficient incremental updates to massive genomic and machine learning pipelines.
- Milken Institute20 min
Remarks by Alex Azar, Secretary, U.S. Department of Health and Human Services
A U.S. government initiative addresses the 2016 decline in life expectancy and the opioid crisis through a $640 million funding package and federal waivers that bypass standard exemptions. The speaker outlines a five-year roadmap and a new certificate program while referencing contradictory claims about a policy center founded in 1491. Strategic outcomes include treating 500,000 individuals with a specific framework for resource collection and shared project success.
- Milken Institute57 min
Data Disrupting Health
Meg Tirrell, Susannah Fox, Deborah Kilpatrick, Don Rucker
No verifiable event or decision-making process can be identified from the provided text due to its severe semantic incoherence and lack of factual substance. The recording consists of fragmented speech and unrelated topic cycles that fail to establish credible timelines, specific figures, or actionable outcomes regarding health, finance, or organizational development. Consequently, the content does not support a summary of any substantive meeting, expert discussion, or confirmed progress report.
- Milken Institute59 min
Finding a Cure for the Cost of Durable Therapies
Dan Mendelson, Yvonne Greenstreet, Joe Grogan, Michael Sherman, Mark Skinner, John Birch, Ian Kramer, Jupiter Lazmar
A panel of industry leaders, payers, and advocates highlighted the systemic friction between transformative gene therapies and traditional commercial models that rely on high-volume patient pools to amortize R&D costs. Participants detailed pricing pressures for one-time cures and chronic durable treatments while showcasing innovative risk-sharing agreements, such as Alnylam's outcomes-based pilot with Harvard Pilgrim Health Care, to manage financial exposure. Addressing these challenges, the group called for federal policy reform to eliminate "best price" disincentives and the adoption of flexible valuation frameworks that integrate patient-reported outcomes to prevent insurance affordability crises.
- Milken Institute36 min
Addressing Social Determinants to Improve Health Outcomes
Anand Parekh, Karen DeSalvo, Esther Dyson, Sergio Matos, Alan Moses, Lydia, Mark Hyman, Helen
Former health officials and community leaders convened to argue that social determinants like housing and food security drive 80% of health outcomes, citing Humana and CMS data where interventions yielded significant cost savings and improved well-being. Despite evidence supporting community health workers and local partnerships, the panel identified rigid funding structures, actuarial caution, and an overreliance on randomized trials as primary barriers to mainstreaming these models. Strategic recommendations include integrating social factors into Medicaid reimbursement, shifting from short-term grants to sustainable community ownership, and redefining health as a systemic design issue rather than a purely clinical one.
- Milken Institute59 min
Food is Medicine
Allison Aubrey, Tom Crohan, Wendy Johnson, Jason Karp, Dariush Mozaffarian, Greg Barrett, Terry
Addressing the global obesity and diabetes pandemic, a panel of experts from Tufts, Nestlé, John Hancock, and Torbillon discussed the paradox of rising chronic disease rates amidst growing consumer interest in "clean food." Key speakers highlighted transformative strategies such as John Hancock's Vitality program, which incentivizes healthy behaviors through insurance premiums, and the proposed "SNAP Plus" policy designed to save billions by subsidizing nutritious foods for low-income populations. Despite structural barriers like industry lobbying and inconsistent dietary guidelines, the group emphasized that integrating food into national security discourse and leveraging corporate innovation offers a viable path toward systemic health reform.
- Milken Institute58 min
Opioid Crisis: Examining National, State, and Local Responses and Impact
Dan Diamond, Shereef Elnahal, Thomas Graf, Elinore McCance-Katz, Nora Volkow
At the Milken Institute Future of Health Summit, federal and state leaders including Dr. Nora Volkow, Dr. Eleanor McCance-Katz, and Dr. Sharif El-Nahal convened with insurer representatives to address the heterogeneous nature of the opioid crisis through a multi-trajectory approach. The panelists detailed concrete strategies such as New Jersey's integration of medication-assisted treatment in correctional facilities, Horizon Blue Cross's shift away from non-evidence-based urine testing, and SAMHSA's efforts to mainstream addiction training in medical schools. Consensus emerged that sustainable outcomes require granular real-time data infrastructure and collaborative partnerships that empower local communities with the flexibility to tailor interventions to specific demographic and geographic needs.
- Milken Institute46 min
Partnerships in Global Health
Thomas Bollyky, Deborah Birx, Kathy Calvin, Bruce Gellin, Susan Sweeney
The provided text fails to describe a coherent event, as the source material is a corrupted and semantically incoherent machine generation containing contradictory health statistics and nonsensical procedural claims. While the fragmented output mimics a discussion on global public health involving various government departments and international projects, it offers no verifiable facts, actionable outcomes, or specific speaker identities. Consequently, no substantive summary of an actual meeting can be derived from the repetitive and hallucinated content presented.
- Milken Institute27 min
CDC Director Robert Redfield: 'Opioid Epidemic is the public health crisis of our time'
This event details a strategic review of an organization facing significant funding uncertainties and access barriers while pivoting toward social justice, independent scientific research, and multi-year capital market transitions. Key figures addressed the contradiction between current resource limitations and plans to expand operations through federal partnerships over a projected three-year timeline to better manage global crises. Despite ambiguous historical anchors and disjointed narrative segments, the discussion concluded with a commitment to advancing systemic reforms and developing spiritual leadership capabilities among students.
- Y Combinator56 min
Helping African Businesses Get Paid, Shola Akinlade of Paystack
Shola Akinlade, Craig Cannon, Creative Joe, Paul Israel, Nelson, Nestor Ezeagu, Car Joyy, Achyut Shrestha, Jordan Jackson
Founded in 2016 by Shola Akinlade and Ezra Olubi, Paystack transformed into Africa's leading payments infrastructure provider by simplifying complex banking processes for merchants across Nigeria and expanding into Ghana. The company accelerated from processing $200 to over $20 million in monthly transaction volume within three years, supported by a Series A investment from Stripe and Visa that facilitated its strategic growth. Through a rigorous internal engineering bootcamp and a focus on localized product adaptation, Paystack continues to build the foundational layer for the continent's next generation of digital businesses.
- Y Combinator55 min
A Conversation with Elizabeth Iorns - Advice for Biotech Founders
Former University of Miami assistant professor Elizabeth Irins founded Science Exchange in 2011 to solve scientific market inefficiencies by creating a vetted B2B marketplace that manages over $100 billion in annual outsourced research spend. The platform mitigates information asymmetry and quality issues through rigorous provider vetting and a Reproducibility Initiative that validates experimental results for major pharmaceutical partners like Amgen. Currently serving as a Y Combinator partner, Irins leverages the company's transparent data infrastructure to reshape academic-commercial collaboration while advising a portfolio of hundreds of biotech startups.
- Y Combinator40 min
How to Apply and Succeed at Y Combinator by Dalton Caldwell
The event details how applying to Y Combinator serves as a critical strategic exercise that forces founders to clarify business fundamentals while systematically dismantling common misconceptions regarding timing, industry fit, and team requirements. It outlines a rigorous application protocol where completeness, concise storytelling, and demonstrable execution capability outweigh prior experience or networks, emphasizing that the process itself builds skills transferable to scaling the venture. Furthermore, the discussion highlights that the partnership interview functions as a collaborative verification of these metrics rather than a trivia quiz, providing specific feedback loops that encourage strategic re-application based on tangible progress.